Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 3Sturge-Weber Syndrome 2Neoplasms 2Nausea 2Marijuana Abuse 2Colonic Neoplasms 2Anxiety Disorders 2Vomiting 1Solid Tumor 1Parasomnias 1Pain 1Glioblastoma 1Dysgeusia 1Drug Resistant Epilepsy 1Colorectal Neoplasms 1Cognitive Dysfunction 1Chemotherapy-Induced Peripheral Neuropathy 1Carcinoma, Intraductal, Noninfiltrating 1Carcinoma, Hepatocellular 1Cachexia 1Breast Carcinoma In Situ 1Breast Cancer Female 1Arthralgia 1Appetitive Behavior 1

Interventions

Megestrol Acetate 7Exercise 6Standard of Care 4Blood Specimen Collection 4Olanzapine 3Ibuprofen 3dermcidin 2Resistance Training 2Physical Therapy Modalities 2Nutrition Assessment 2Mirtazapine 2Melatonin 2Enteral Nutrition 2Diet Therapy 2Cyproheptadine 2testosterone enanthate 1telotristat ethyl 1remune 1olanzapine-fluoxetine combination 1nabiximols 1nabilone 1irinotecan sucrosofate 1fucoidan 1bermekimab 1anamorelin 1Vitamin D 1Ultrasonography 1Retrospective Studies 1Radiotherapy 1Powders 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Cachexia × Cannabidiol × Clear all
NCT04585841 2023-07-24

The Effect of Cannabidiol on Lean Body Mass in Patients Receiving Chemotherapy

University of Copenhagen

Phase 1 Completed
32 enrolled

Appetitive Behavior, Cachexia, Marijuana Abuse, Dysgeusia, Nausea, Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡